| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/21/1997 | US5596105 Viricides for treatment of aids htlv virus and autogenesis inhibitors |
| 01/21/1997 | US5596002 Treatment of antibiotic resistant microorganisms |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595986 Stably storable and readily water soluble composition of cephalosporin for injections |
| 01/21/1997 | US5595884 Papillomavirus E2 transactivation repressor proteins and DNA |
| 01/21/1997 | US5595742 Antimicrobial agent for staphylococcus |
| 01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
| 01/21/1997 | CA2009505C Inhibitor of herpesvirus adsorption |
| 01/20/1997 | CA2181308A1 Improving the tolerability of pharmaceutically active beta-amino acids |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/16/1997 | WO1997001562A1 Nitroimidazole antibacterial compounds and methods of use thereof |
| 01/16/1997 | WO1997001552A1 Triazole antifungal agents |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001349A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 01/16/1997 | WO1997001347A1 Pharmaceutical composition for wound healing |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | WO1997001330A1 Novel adjuvant compositions and vaccine formulations comprising same |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/16/1997 | CA2219904A1 Novel adjuvant compositions and vaccine formulations comprising same |
| 01/16/1997 | CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/15/1997 | EP0753310A1 Legionellosis vaccines and methods for their production |
| 01/15/1997 | EP0753305A1 Anti-HIV composition and method for treating HIV infection with an anti-HIV agent containing crude drug |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753061A1 Vaccine compositions |
| 01/15/1997 | EP0753055A1 Enzymatic antimicrobial compositions |
| 01/15/1997 | EP0753012A1 A new 78 residue polypeptide (nk-lysine) and its use |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753002A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| 01/15/1997 | EP0752994A1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES, THEIR PREPARATION AND DRUGS CONTAINING THEM |
| 01/15/1997 | EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752992A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752989A1 Thiazolylpyrazolinones and their use for protecting technical materials |
| 01/15/1997 | EP0752888A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| 01/15/1997 | EP0752887A1 Immunodeficiency recombinant poxvirus |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752871A1 Adhesion inhibiting composition |
| 01/15/1997 | EP0752867A1 Selective cell proliferation |
| 01/15/1997 | EP0671938A4 Novel biologically active peptides and uses therefor. |
| 01/15/1997 | EP0642528B1 Phosphotriester-type biologically active compounds |
| 01/15/1997 | EP0625986B1 Oligothionucleotides |
| 01/15/1997 | EP0625178B1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 01/15/1997 | EP0539484B1 Method for preparing sulphonylpristinamycin iib |
| 01/15/1997 | EP0527753B1 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 01/15/1997 | EP0519971B1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE |
| 01/15/1997 | EP0495919B1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs |
| 01/15/1997 | CN1140414A Use of anti-TNF antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
| 01/15/1997 | CN1140175A 7-acyl-3-(substd. carbamoyloxy) cephem compounds and their preparation process |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/14/1997 | US5594135 Bactericides |
| 01/14/1997 | US5594133 Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropinonyloxy)-ethyl-3-cephem-4-carboxylate |
| 01/14/1997 | US5594132 7-acylamino-3-substituted cephalosporanic acid derivatives |
| 01/14/1997 | US5594122 Bind to conserved regions of human immunodeficiency virus genetic material to prevent expression thereof |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593985 Cephalosporin compounds |
| 01/14/1997 | US5593984 Cephalosporin derivatives |
| 01/14/1997 | US5593960 Producing cyclomarin a from fermentation of streptomyces |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593681 Glycine anhydride dimethylol as a biocide and preservative |
| 01/14/1997 | US5593658 Medical compositions |
| 01/14/1997 | CA2088671C Use of canps-inhibitors in pharmaceutical preparations |
| 01/14/1997 | CA2070366C Prophylactic/therapeutic composition for swine pleuropneumonia |
| 01/14/1997 | CA2020062C Antibiotic agent |
| 01/14/1997 | CA1338849C Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/14/1997 | CA1338848C Hydrogenated derivatives of antibiotic a/16686 |
| 01/14/1997 | CA1338842C Cephem compound and a process for preparation thereof |
| 01/09/1997 | WO1997000963A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | WO1997000882A1 Therapeutic compounds |
| 01/09/1997 | WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 01/09/1997 | WO1997000855A1 Herpes ribonucleotide reductase inhibitors |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000697A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/09/1997 | WO1997000696A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 01/09/1997 | WO1997000694A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 01/09/1997 | WO1997000689A1 Antiviral agents |
| 01/09/1997 | WO1997000679A1 Biflavanoids and derivatives thereof as antiviral agents |
| 01/09/1997 | WO1997000677A1 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 01/09/1997 | CA2225341A1 Biflavanoids and derivatives thereof as antiviral agents |
| 01/09/1997 | CA2225318A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | CA2225247A1 Therapeutic compounds |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2222455A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |